Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma

European Journal of Clinical Pharmacology

Volumn 59, Issue 7, 2003, Pages 527-531

  Güngör, Kivanc ^a   Özkur, Mehtap ^a   Cascorbi, Ingolf ^b   Brockmöller, Jürgen ^c   Bekir, Necdet ^a   Roots, Ivar ^d   Aynacioglu, A Sükrü ^d,e,f  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e PAMUKKALE UNIVERSITY   (Turkey)

^f Epidauros Biotechnologie AG   (Germany)

Author keywords

Beta 2 adrenergic receptor; Glaucoma; Polymorphism

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLUTAMIC ACID; GLUTAMINE; GLYCINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; AQUEOUS HUMOR FLOW; ARTICLE; BLOOD SAMPLING; DRUG EFFECT; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRABECULAR MESHWORK;

CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROPHTHALMOS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0242329688     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0658-3     Document Type: Article

References (37)

1. Shiose Y (1990) Intraocular pressure: new perspectives. Surv Ophthalmol 34:413-435
2. Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389-393
3. Shields MB (1992) Textbook of Glaucoma. Williams-Wilkins, Baltimore, pp 167-483
4. Coleman AL, Brigatti L (2001) The glaucomas. Minerva Med 92:365-379
5. Armaly MF (1967) The genetic determination of ocular pressure in the normal eye. Arch Ophthalmol 78:187
6. Schwartz TJ, Reuling FH, Feinleib M (1975) Size of the physiologic cup of the optic nerve head: heredity and environmental factors. Arch Ophthalmol 93:776
7. Johnson AT, Alward WLM, Sheffield VC, Stone EM (1996) Genetics and glaucoma. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas (glaucoma therapy), Mosby, St. Louis, pp 39-54
8. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC (1997) Identification of a gene that causes primary open angle glaucoma. Science 275:668-670
9. Mukhopadhyay A, Acharya M, Mukherjee S, Ray J, Choudhury S, Khan M, Ray K (2002) Mutations in MYOC gene of Indian primary open angle glaucoma patients. Mol Vis 8:442-448
10. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295:1077-1079
11. Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y, Tsai SW (2003) Association of tumour necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye 17:31-34
12. Stoilova D, Child A, Trifan OC, Crick RP, Coakes RL, Sarfarazi M (1996) Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics 36:142-150
13. Wirtz MK, Samples JR, Kramer PL, Rust K, Topinka JR, Yount J, Koler RD, Acott TS (1997) Mapping a gene for adult-onset primary open-angle glaucoma to chromosome 3q. Am J Hum Genet 60:296-304
14. Wirtz MK, Samples JR, Rust K, Lie J, Nordling L, Schilling K, Acott TS, Kramer PL (1999) GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch Ophthalmol 117:237-241
15. Trifan OC, Traboulsi EI, Stoilova D, Alozie I, Nguyen R, Raja S, Sarfarazi M (1998) A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am J Ophthalmol 126:17-28
16. De Luise V, Anderson DR (1983) Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol 28:1-19
17. Sarfarazi M, Akarsu AN, Hossain A, Turacli ME, Aktan SG, Barsoum-Homsy M, Chevrette L, Sayli BS (1995) Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 30:171-177
18. Akarsu AN, Turacli ME, Aktan SG, Barsoum-Homsy M, Chevrette L, Sayli BS, Sarfarazi M (1996) A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region. Hum Mol Genet 5:1199-1203
19. Stoilov I, Akarsu AN, Sarfarazi M (1997) Identification of three different truncating mutations in cytochrome P4501B1(CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6:641-647
20. Bejjani BA, Lewis RA, Tomey KF, Anderson KL, Dueker DK, Jabak M, Astle WF, Otterud B, Leppert M, Lupski JR (1998) Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 62:325-333
21. Ohtake Y, Tanino T, Suzuki Y, Miyata H, Taomoto M, Azuma N, Tanihara H, Araie M, Mashima Y (2003) Phenotype of cytochrome P4501B1 gene (CYP1B1) mutations in Japanese patients with primary congenital glaucoma. Br J Ophthalmol 87:302-304
22. Wax MB, Molinoff PB (1987) Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci 28:420-430
23. Mittag TW (1996) Adrenergic and dopaminergic drugs in glaucoma. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas (glaucoma therapy). Mosby, St. Louis, pp 1409-1424
24. Crider JY, Sharif NA (2002) Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized humantrabecular meshwork and non-pigmented ciliary epithelial cells. J Ocul Pharmacol Ther 18:221-230
25. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334-339
26. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419
27. Liggett SB (1997) Polimorphism of the beta-2 adrenergic receptor and asthma. Am J Respir Crit Care Med 156:S156-S162
28. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P (1998) Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 53:1455-1460
29. Turki J, Pak J, Green SA, Martin RJ, Liggett SB (1995) Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 95:1635-1641
30. 2-adrenergic receptor among Turks. Br J Clin Pharmacol 48:761-764
31. Green SA, Turki J, Bejarano P, Hall IP, Ligget SB (1995) Influence of the beta2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 13:25-33
32. 2-adrenoceptor polymorphisms: are they clinically important? Thorax 51:351-353
33. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116-23121
34. Hopes E, McDougall C, Christie G Dewar J, Wheatley A, Hall IP, Helms PJ (1998) Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ 316:664-669
35. 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42:98-101
36. 2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101:2877-2882
37. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R (1997) Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100:3184-3188